ContrAl results: 78% succeed

The ContrAl Method has been practised in Finland and abroad since 1996. We have treated thousands of people, and our results speak for themselves:  three out of four customers succeed.

78% succeeds

78% of all people who undergo the programme are able to either fulfill WHO limits for moderate use of alcohol or halve the amounts they consume.

Scientifically proven

The analysis of the data collected from our clinics suggests that the amount of alcohol consumed and the decrease in drinking cravings was statistically significant (p<0.001). Read more. 

Liver recovers

Liver enzymes are common markers of excessive alcohol drinking, and decrease in them usually indicates decrease in drinking. For example, the Gamma GT values of our patients fell from 133,6 IU/l to 71,0 IU/l during the treatment.

Mood improves

The patients’ mood was significantly improved due to the treatment. The mood of the patients in the beginning of the treatment averaged to 8.2 pts (moderate depression), and at the end of the treatment to 3.6 pts (normal mood) on Beck depression inventory.

Clientele

Our clientele consists of a wide variety of backgrounds, ethnicities and cultures, so therefore a typical Contral customer can’t be identified. However, a small sampling of our clientele reveals the following:

  • Gender

    Women 43 people (24%), men 136 people (76%).

  • Age

    Average 47 yrs, youngest 22 yrs, oldest 71 yrs.

  • Previous treatment of alcohol problems

    Yes: 94 people (53%), no: 52 people (29%), data missing: 33 people (18%).

  • Starting point

    At the start of the program, 97% scored positive on the CAGE alcohol problems screening questionnaire and 92% could be classified as alcohol dependant according to DSM IIR criteria.

  • Background data

    The majority of our clients are normal people in full-time jobs.

Liver enzymes are common markers of excessive alcohol drinking. Decrease in Gamma GT values usually indicates decrease in drinking

This graph shows how alcohol consumption decreased after starting the Contral programme, in comparison to the average during the two weeks before treatment.